Literature DB >> 18074348

Risks of cancer among a cohort of 23,935 men and women with osteoporosis.

Katherine A McGlynn1, Gloria Gridley, Lene Mellemkjaer, Louise A Brinton, Kenneth C Anderson, Neil E Caporaso, Ola Landgren, Jorgen H Olsen.   

Abstract

Low hormone levels among persons with osteoporosis may decrease risk of some cancers. Other osteoporosis risk factors, such as smoking and alcohol consumption, however, may increase risk. As these deleterious factors are more often associated with osteoporosis diagnosed prior to age 70 years, cancer risk may be higher in these younger persons than in the general population. To examine this hypothesis, a cohort study of 23,935 persons with osteoporosis was conducted in Denmark. Patients hospitalized with osteoporosis between 1978 and 1993 were identified in the Danish Inpatient Register. Linkage to the Danish Cancer Registry identified all cancer outcomes through 2003. Standardized incidence ratios (SIR) and 95% confidence intervals (95%CI) were calculated to compare cancer incidence in the cohort with that in the general population. Persons diagnosed prior to age 70 years were at increased cancer risk (women: SIR = 1.11, 95%CI = 1.04-1.19; men: SIR = 1.31, 95%CI = 1.13-1.50) due, in part, to increased risks of cancers of the buccal cavity, esophagus, liver, pancreas and lung. Persons diagnosed at ages 70 and older were at decreased risk (women: SIR = 0.91, 95%CI = 0.87-0.96; men: SIR = 0.89, 0.77-1.01) due, in part, to decreased risks of breast, endometrial, colon, rectal and brain cancers in women and prostate cancer in men. These results suggest that risk factors associated with earlier onset osteoporosis may be associated with increased risk of cancer. Conversely, factors associated with later onset osteoporosis may be related to a decreased risk of cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18074348     DOI: 10.1002/ijc.23290

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Multimorbidity in women with and without osteoporosis: results from a large US retrospective cohort study 2004-2009.

Authors:  C D O'Malley; N Tran; C Zapalowski; N Daizadeh; T P Olenginski; J A Cauley
Journal:  Osteoporos Int       Date:  2014-05-24       Impact factor: 4.507

2.  Use of bisphosphonates and reduced risk of colorectal cancer.

Authors:  Gad Rennert; Mila Pinchev; Hedy S Rennert; Stephen B Gruber
Journal:  J Clin Oncol       Date:  2011-02-14       Impact factor: 44.544

3.  Bone fractures and incident epithelial ovarian cancer in a prospective cohort study.

Authors:  Kim N Danforth; Catherine Schairer; Arthur Schatzkin; James V Lacey
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

4.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

5.  The impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registers.

Authors:  U C Bang; L Hyldstrup; J E B Jensen
Journal:  Osteoporos Int       Date:  2013-08-14       Impact factor: 4.507

6.  Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database.

Authors:  Yana Vinogradova; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ Open       Date:  2012-01-12       Impact factor: 2.692

7.  Bone Density in Patients with Cervical Cancer or Endometrial Cancer in comparison with Healthy Control; According to the stages.

Authors:  Yubin Lee; Ari Kim; Heung Yeol Kim; Wan Kyu Eo; Eun Sil Lee; Sungwook Chun
Journal:  J Cancer       Date:  2015-06-10       Impact factor: 4.207

8.  Changes in bone density after cancer treatment in patients with cervical and endometrial cancer.

Authors:  Young Lim Oh; Man Soo Yoon; Dong Soo Suh; Ari Kim; Min Joung Kim; Ji Young Lee; Yong Jung Song; Yong Il Ji; Ki Hyung Kim; Sungwook Chun
Journal:  J Cancer       Date:  2015-01-01       Impact factor: 4.207

9.  Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.

Authors:  Yana Vinogradova; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ       Date:  2013-01-16

10.  Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case-control studies using two primary-care databases.

Authors:  Y Vinogradova; C Coupland; J Hippisley-Cox
Journal:  Br J Cancer       Date:  2013-07-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.